Burning Rock Biotech BNR reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM.
Here's what investors need to know about the announcement.
Burning Rock Biotech missed estimated earnings by 5.71%, reporting an EPS of $-0.37 versus an estimate of $-0.35.
Revenue was down $179 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 1.67% drop in the share price the next day.
Here's a look at Burning Rock Biotech's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Burning Rock Biotech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.